We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$65.7B
AUM Growth
+$7.59B
Cap. Flow
-$1.34B
Cap. Flow %
-2.05%
Top 10 Hldgs %
12.37%
Holding
7,215
New
735
Increased
2,740
Reduced
3,074
Closed
505

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$245M
2
KEY icon
KeyCorp
KEY
+$199M
3
RTX icon
RTX Corp
RTX
+$183M
4
EMC
EMC CORPORATION
EMC
+$170M
5
RL icon
Ralph Lauren
RL
+$167M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$245M
2
USB icon
US Bancorp
USB
+$216M
3
AAPL icon
Apple
AAPL
+$207M
4
V icon
Visa
V
+$188M
5
BAC icon
Bank of America
BAC
+$177M

Sector Composition

Rank Sector Weight
1 Financials 9.51%
2 Consumer Discretionary 7.62%
3 Energy 7.06%
4 Technology 6.57%
5 Industrials 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDY
6176
DELISTED
HYPERDYNAMICS CORP (NEW)
HDY
$18K ﹤0.01%
4,003
+2,348
+142% +$10.4K
CHYR
6177
DELISTED
CHYRONHEGO CORP COM STK (NY)
CHYR
$18K ﹤0.01%
+12,103
New +$18.9K
CTIC
6178
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$18K ﹤0.01%
+1,103
New +$12.8K
PGH
6179
PUT
DELISTED
Pengrowth Energy Corporation
PGH
$18K ﹤0.01%
3,000
-12,600
-81% -$70.7K
PDLI
6180
PUT
DELISTED
PDL BioPharma, Inc.
PDLI
$18K ﹤0.01%
2,200
-10,300
-82% -$82.8K
SSN
6181
DELISTED
Samson Oil & Gas Limited
SSN
$18K ﹤0.01%
+3,721
New +$19K
SVA
6182
CALL
DELISTED
Sinovac Biotech, Ltd
SVA
$18K ﹤0.01%
3,000
-300
-9% -$1.43K
CTLP
6183
DELISTED
Cantaloupe
CTLP
$17K ﹤0.01%
+10,816
New +$21.1K
FOLD
6184
CALL
DELISTED
Amicus Therapeutics
FOLD
$17K ﹤0.01%
7,500
+3,800
+103% +$9.54K
FOLD
6185
DELISTED
Amicus Therapeutics
FOLD
$17K ﹤0.01%
7,436
-12,650
-63% -$31.7K
IDN icon
6186
Intellicheck
IDN
$75.9M
$17K ﹤0.01%
+3,735
New +$16K
IRWD icon
6187
CALL
Ironwood Pharmaceuticals
IRWD
$714M
$17K ﹤0.01%
1,672
-15,522
-90% -$152K
TBHC
6188
PUT
DELISTED
The Brand House Collective
TBHC
$17K ﹤0.01%
+900
New +$16.5K
RMTI icon
6189
Rockwell Medical
RMTI
$29.6M
$17K ﹤0.01%
14
-18
-56% -$12.2K
AAU
6190
DELISTED
Almaden Minerals Ltd
AAU
$17K ﹤0.01%
+12,433
New +$20.2K
ONCT
6191
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$17K ﹤0.01%
6
-25
-81% -$124K
WWE
6192
PUT
DELISTED
World Wrestling Entertainment
WWE
$17K ﹤0.01%
1,700
-100
-6% -$1.03K
EPAY
6193
PUT
DELISTED
Bottomline Technologies Inc
EPAY
$17K ﹤0.01%
+600
New +$17.1K
XBKS
6194
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$17K ﹤0.01%
+1,220
New +$19.7K
ELOS
6195
CALL
DELISTED
Syneron Medical Ltd
ELOS
$17K ﹤0.01%
2,000
+1,400
+233% +$12.1K
MCGC
6196
PUT
DELISTED
MCG CAP CORP
MCGC
$17K ﹤0.01%
3,300
-6,500
-66% -$33.5K
SVBL
6197
DELISTED
SILVER BULL RESOURCES, INC
SVBL
$17K ﹤0.01%
48,360
+35,545
+277% +$13.2K
EDS
6198
DELISTED
EXCEED COMPANY LTD ORD SHS
EDS
$17K ﹤0.01%
+11,233
New +$15.3K
IKAN
6199
DELISTED
IKANOS COMMUNICATIONS INC COM STK NEW (DE)
IKAN
$17K ﹤0.01%
+1,336
New +$17.2K
PRIS
6200
DELISTED
PROMOTORA DE INFORMACIONES SA ADR REPSTG 4 CL A SHS
PRIS
$17K ﹤0.01%
+10,009
New +$11.1K

Similar funds

Ken Griffin's Q3 2013 Portfolio in Review

As of Q3 2013, Ken Griffin held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Ken Griffin's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.

By sector, the portfolio is most concentrated in Financials at 9.5% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Energy.

  • Ken Griffin's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
  • Ken Griffin added most to Philip Morris in Q3 2013, an estimated $245M increase.
  • Ken Griffin's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
  • Ken Griffin fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
  • Ken Griffin's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
  • Ken Griffin opened 735 new positions and closed 505 in Q3 2013.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $65.7B.

Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.